Kenergy Scientific, Inc. - FORM 10-K - EX-10.27 - EXHIBIT 10.27 - April 13, 2012

Attached files
FileFilename
XML - IDEA: XBRL DOCUMENT - Kenergy Scientific, Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - Kenergy Scientific, Inc.R20.htm
XML - IDEA: XBRL DOCUMENT - Kenergy Scientific, Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - Kenergy Scientific, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - Kenergy Scientific, Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - Kenergy Scientific, Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - Kenergy Scientific, Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - Kenergy Scientific, Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - Kenergy Scientific, Inc.R19.htm
XML - IDEA: XBRL DOCUMENT - Kenergy Scientific, Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - Kenergy Scientific, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - Kenergy Scientific, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - Kenergy Scientific, Inc.R18.htm
XML - IDEA: XBRL DOCUMENT - Kenergy Scientific, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - Kenergy Scientific, Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Kenergy Scientific, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Kenergy Scientific, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - Kenergy Scientific, Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - Kenergy Scientific, Inc.R8.htm
EXCEL - IDEA: XBRL DOCUMENT - Kenergy Scientific, Inc.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - Kenergy Scientific, Inc.R9.htm
EX-32.1 - EXHIBIT 32.1 - Kenergy Scientific, Inc.exh32_1.htm
EX-31.1 - EXHIBIT 31.1 - Kenergy Scientific, Inc.exh31_1.htm
EX-10.28 - EXHIBIT 10.28 - Kenergy Scientific, Inc.exh10_28.htm
EX-10.26 - EXHIBIT 10.26 - Kenergy Scientific, Inc.exh10_26.htm
EX-10.25 - EXHIBIT 10.25 - Kenergy Scientific, Inc.exh10_25.htm
EX-10.24 - EXHIBIT 10.24 - Kenergy Scientific, Inc.exh10_24.htm
EX-3.5 - EXHIBIT 3.5 - Kenergy Scientific, Inc.exh3_5.htm
10-K - KENERGY SCIENTIFIC, INC. 10-K - Kenergy Scientific, Inc.kenergy10k.htm
 
Exhibit 10.27
 
PROMISSORY NOTE (No. 007)
(December 28, 2009)
 
WHEREAS, GlynnTech, Inc. of 24 Mine Street, Flemington, New Jersey has sold patent rights and technology relating to cancer drug delivery systems to SpeechSwitch, Inc. of 6 Minneakoning Rd., Flemington, New Jersey 08822, under an Agreement of June 18, 2009, and a portion of the purchase price in the amount of $ 125,000.00 was contingent upon a pending patent application successfully issuing into a United States issued patent; and,
 
WHEREAS, said pending patent application did issue on December 28, 2009 into United States Patent Number US 7,637,889 B2 entitled “ Drug Delivery Device With Sliding Valve And Methodology” , causing the incurrence of the remaining obligation of $ 125,000.00 to become due one year from the issue date of said patent, to be secured by Note(s) in that amount upon issuance of said patent with a one year due date, by mutual agreement to be in the form of two notes for $ 50,000.00 each (designated as Notes 006 and 007), and one note for $ 25,000.00 (designated as Note 008), this being Note 007 for $ 50,000.00, and SpeechSwitch, Inc. has agreed to make payment on said Notes one year henceforth, now, therefore,
 
SpeechSwitch, Inc. agrees to pay GlynnTech, Inc. a sum of $ 50,000.00 on or before December 29, 2010, at no interest. This Note shall be in default if not paid in full within 5 days from the due date. No interest shall accrue during the term hereof. However, GlynnTech, Inc, reserves the right to statutory interest after default, at its option.
 
 
   /s/ Kenneth P Glynn                                                 
   Kenneth P. Glynn, President, SpeechSwitch, Inc.
   
   /s/ Alex P Glynn                                                        
   Alex P. Glynn, Vice President, GlynnTech, Inc.
   
   
 
 
 
 
 
 
 

User Contributions:

Comment about this document or add new information about this topic:

CAPTCHA


This web site and associated pages are not associated with, endorsed by, or sponsored by Kenergy Scientific, Inc. and has no official or unofficial affiliation with Kenergy Scientific, Inc.


Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site.  Use at your own risk. This website is not associated with the SEC

Some parts © 2013 Advameg, Inc.